AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
Apr 17 2024
News
How Moderna’s CIO helps steer the drugmaker’s post-COVID evolution
When Brad Miller became the chief information officer at drugmaker Moderna in early 2023, he already had a strong background in finance and technology, but no expertise in health care. “Learning about pharma and biotech was really critical,” says Miller, who had previously been CIO at Capital One, held leadership roles at Mastercard, and spent 17 years in engineering at Amazon and Microsoft.
FortuneApr 11 2024
News
Moderna halts vaccine plant in Africa amid dwindling orders
Moderna has paused its efforts to build an mRNA manufacturing facility in Kenya while it determines future demand for COVID-19 vaccines on the African continent, the firm said in a statement Thursday. Moderna’s plan was part of efforts to widen access to vaccines that have remained out of reach to large parts of the world. Africa has been trying to reduce the continent’s reliance on the rest
The Boston GlobeApr 19 2024
News
Moderna CEO says AI will help scientists understand ‘most diseases’ in 3 to 5 years
Moderna CEO Stéphane Bancel said Thursday that with the help of AI scientists will likely “understand most diseases” in the next three to five years, in what will be a “first for humans on the planet.”
“If you understand the disease, you will find a way to go fix it,” Bancel said at Semafor’s World Economy Summit. “The reason we still have people dying of cancer, people suffering from
SemaforApr 11 2024
News
Moderna halts plans to build Kenya vaccine plant as Covid shot demand plunges
Moderna on Thursday said it has paused plans to build a vaccine manufacturing site in Kenya after a steep drop in demand for its Covid vaccines. The biotech company said it has not received any vaccine orders for Africa since 2022 and has taken more than $1 billion in losses and write-downs related to the cancellation of previous orders from the continent. Moderna's decision aligns with its
CNBCMar 27 2024
News
Moderna moves three vaccines into final stage trials as it works to rebound from Covid slump
Moderna has more to offer beyond its Covid vaccine.
The biotech company Wednesday announced positive clinical trial data on three experimental vaccines against other viruses. The company is moving those shots to final stage studies, it said.
The update brings Moderna a step closer to having multiple products on the market, which it badly needs amid plunging demand for Covid
CNBCNov 07 2023
News
Moderna Inc. stock outperforms competitors on strong trading day
Shares of Moderna Inc. MRNA, rallied 2.21% to $73.66 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP, rising 0.90% to 13,639.86 and the Dow Jones Industrial Average DJIA, rising 0.17% to 34,152.60. Moderna Inc. closed $143.59 short of its 52-week high ($217.25), which the company achieved on December 14th. The
MarketWatchMar 22 2023
News
Moderna COVID vaccines expected to cost $130
Moderna is expected to charge about $130 for a single dose of its COVID-19 vaccine once the U.S. government stops buying the shots, according to Reuters.
"There are different customers negotiating different prices right now, which is why it's a little bit complicated," president Stephen Hoge told Reuters on Monday during an interview.
Hoge made his comments two days before
Fox BusinessDec 07 2020
Analysis
How Moderna’s Vaccine Works
Moderna, a Massachusetts-based vaccine developer, partnered with the National Institutes of Health to develop and test a coronavirus vaccine known as mRNA-1273. A clinical trial demonstrated that the vaccine has an efficacy rate of 94.1 percent in preventing Covid-19.
New York Times (News)May 21 2020
News
Moderna's Early Vaccine Results
This Abridge News topic aggregates four unique arguments on different sides of the debate. Here are the quick facts to get you started:
THE QUICK FACTS
On Monday, biotech company Moderna Therapeutics announced in a press release "positive" interim phase 1 data for a COVID-19 vaccine trial. Moderna's stock valuation subsequently surged.The company only disclosed Abridge NewsSep 11 2023
News
FDA approves updated Covid vaccines from Pfizer and Moderna as hospitalizations rise
The Food and Drug Administration on Monday approved updated Covid vaccines from Pfizer and Moderna, putting the shots on track to reach Americans within days as U.S. hospitalizations from the virus rise.
The new vaccines, which target the omicron variant XBB.1.5, are approved for people 12 and older and are authorized under emergency use for children 6 months through 11 years old,
CNBC